Relevance of plasma level determination of L-Dopa and 3-O-methyldopa in Parkinson's disease - Discussion

被引：0
|
作者：
Przuntek
Horowski
Riederer
Reichmann
Gerlach
Baas
Eichhorn
Kuhn
Schwarz
Henneberg
Ulm
Gehlen
机构：
来源：
AKTUELLE NEUROLOGIE | 1998年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S282 / S285
页数：4
相关论文
共 50 条
  • [41] A NEW METHOD FOR THE DETERMINATION OF L-DOPA AND 3-O-METHYLDOPA IN PLASMA AND CEREBROSPINAL-FLUID USING GAS-CHROMATOGRAPHY AND ELECTRON-CAPTURE NEGATIVE-ION MASS-SPECTROMETRY
    DEJONG, APJM
    KOK, RM
    CRAMERS, CA
    WADMAN, SK
    HAAN, E
    CLINICA CHIMICA ACTA, 1988, 171 (01) : 49 - 61
  • [42] Simultaneous determination of levodopa and 3-O-methyldopa in patients with parkinson's disease by high-performance liquid chromatography with electrochemical detection
    Adamiak-Giera, Urszula
    Gawronska-Szklarz, Barbara
    JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2018, 41 (19-20) : 1047 - 1051
  • [43] Effect of L-dopa on gastric motility in Parkinson's disease
    Albani, G.
    El Assawy, N.
    Cataldo, S.
    Mauro, A.
    JOURNAL OF NEUROLOGY, 2007, 254 : 64 - 65
  • [44] L-DOPA and cortical associative plasticity in Parkinson's disease
    Suppa, Antonio
    Bologna, Matteo
    Berardelli, Alfredo
    CLINICAL NEUROPHYSIOLOGY, 2013, 124 (04) : 638 - 639
  • [45] THE L-DOPA RESPONSE IN PATHOLOGICALLY CONFIRMED PARKINSON'S DISEASE
    Pitz, Vanessa
    Malek, Naveed
    Grosset, Katherine A.
    Grosset, Donald G.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (10):
  • [46] Paradoxical response to L-dopa and apomorphine in the Parkinson's disease
    García-Soldevilla, MA
    Puertas, I
    Barcenilla, B
    Sayed, Y
    García-Albea, E
    Jiménez-Jiménez, FJ
    MOVEMENT DISORDERS, 2002, 17 : S96 - S96
  • [47] Parkinson's disease, L-DOPA, and endogenous morphine: A revisit
    Stefano, George B.
    Mantione, Kirk J.
    Kralickova, Milena
    Ptacek, Radek
    Kuzelova, Hana
    Esch, Tobias
    Kream, Richard M.
    MEDICAL SCIENCE MONITOR, 2012, 18 (08): : RA133 - RA137
  • [48] L-DOPA for Parkinson's disease-a bittersweet pill
    Lane, Emma L.
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2019, 49 (03) : 384 - 398
  • [49] Impact of the catechol-O-methyltransferase Val158Met polymorphism on the pharmacokinetics of l-dopa and its metabolite 3-O-methyldopa in combination with entacapone
    Yamamoto, Joe
    Omura, Tomohiro
    Kasamo, Sachiko
    Yamamoto, Shota
    Kawata, Masayoshi
    Yonezawa, Atsushi
    Taruno, Yosuke
    Endo, Hisako
    Aizawa, Hitoshi
    Sawamoto, Nobukatsu
    Matsubara, Kazuo
    Takahashi, Ryosuke
    Tasaki, Yoshikazu
    JOURNAL OF NEURAL TRANSMISSION, 2021, 128 (01) : 27 - 36
  • [50] L-DOPA: A scapegoat for accelerated neurodegeneration in Parkinson's disease?
    Lipski, Janusz
    Nistico, Robert
    Berretta, Nicola
    Guatteo, Ezia
    Bernardi, Giorgio
    Mercuri, Nicola B.
    PROGRESS IN NEUROBIOLOGY, 2011, 94 (04) : 389 - 407
12345